Federal (United States) · Regulations
Subpart I — Payment for Drugs
16 sections
16 sections
- 42 C.F.R. § 447.500Basis and purpose.
- 42 C.F.R. § 447.502Definitions.
- 42 C.F.R. § 447.504Determination of average manufacturer price.
- 42 C.F.R. § 447.505Determination of best price.
- 42 C.F.R. § 447.506Authorized generic drugs.
- 42 C.F.R. § 447.507Identification of inhalation, infusion, instilled, implanted, or injectable drugs (5i drugs).
- 42 C.F.R. § 447.508Exclusion from best price of certain sales at a nominal price.
- 42 C.F.R. § 447.509Medicaid drug rebates (MDR).
- 42 C.F.R. § 447.510Requirement and penalties for manufacturers.
- 42 C.F.R. § 447.511Requirements for States.
- 42 C.F.R. § 447.512Drugs: Aggregate upper limits of payment.
- 42 C.F.R. § 447.514Upper limits for multiple source drugs.
- 42 C.F.R. § 447.516Upper limits for drugs furnished as part of services.
- 42 C.F.R. § 447.518State plan requirements, findings, and assurances.
- 42 C.F.R. § 447.520Federal Financial Participation (FFP): Conditions relating to physician-administered drugs.
- 42 C.F.R. § 447.522Optional coverage of investigational drugs and other drugs not subject to rebate.